Anti-TGF-beta receptor II antibodies
US8147834B2 · kind B2 · utility
2Cited by
2References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 29, 2009 |
| Grant date | Apr 3, 2012 |
| Priority date | — |
| Expiry date | Aug 31, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to antibodies against human transforming growth factor beta receptor II (TGFβRII), pharmaceutical compositions comprising antibodies and methods of using the antibodies, alone or in combination, for example, for treating cancer and fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.